GenVec is a biopharmaceutical company focused on using differentiated, proprietary technologies in the creation of superior therapeutics and vaccines. The primary component of the company’s strategy is developing and commercializing its products through collaborations. GenVec is working with leading companies as well as the U.S. government to support a product portfolio addressing the prevention and treatment of various significant human and animal health concerns. For more information, visit the company’s Web site: http://www.genvec.com